Pregnancy Hypertension
Papers 1127
1 page of 113 pages (1,127 results)
#1Célia Regina Trindade (UFES: Universidade Federal do Espírito Santo)H-Index: 2
#2Maria Regina Torloni (UNIFESP: Federal University of São Paulo)H-Index: 35
Last. Sue Yazaki Sun (UNIFESP: Federal University of São Paulo)H-Index: 12
view all 4 authors...
Abstract null null Introduction null Preeclampsia (PE) affects 2–8% of pregnancies and is one of the main causes of maternal morbidity and mortality worldwide. Early identification of pregnant women at higher risk for PE would allow the use of interventions to reduce adverse maternal and perinatal outcomes. null null null Objective null To assess the ability of bioelectrical impedance analysis (BIA) in pregnancy to predict the development of PE. null null null Methods null This prospective cohor...
#1Jiang-Shan Tan (Peking Union Medical College)
#2Ning-Ning Liu (PKU: Peking University)
Last. Lu Hua (Peking Union Medical College)H-Index: 3
view all 0 authors...
Aims null The aim of this study was to apply the Mendelian randomization (MR) design to explore the potential causal association between COVID-19 and the risk of hypertension disorders in pregnancy. null Methods null Our primary genetic instrument comprised 8 single-nucleotide polymorphisms (SNPs) associated with COVID-19 at genome-wide significance. Data on the associations between the SNPs and the risk of hypertension disorders in pregnancy were obtained from study based on a very large cohort...
#2Kristel Van Calsteren (Katholieke Universiteit Leuven)H-Index: 23
Last. Leonardo GucciardoH-Index: 27
view all 8 authors...
Abstract null null Objective null To evaluate the economic impact of introducing the soluble fms-like null tyrosine kinase (sFlt-1) to placental growth factor (PlGF) ratio test into clinical practice in Belgium for the prediction of preeclampsia (PE). null Study design: We developed a one-year time-horizon decision tree model to evaluate the short-term costs associated with the introduction of the sFlt-1/PlGF test for guiding the management of women with suspected PE from the Belgian public heal...
#1Yanfang Peng (NU: Nanjing University)H-Index: 1
#2Dan Liu (NU: Nanjing University)H-Index: 5
Last. Mingming Zheng (NU: Nanjing University)H-Index: 6
view all 0 authors...
#1M.P.A. Sailakshmi (Rajarajeswari Medical College and Hospital)
#2M.R. Prabhu (Rajarajeswari Medical College and Hospital)
Last. B.M. Rupakala (Rajarajeswari Medical College and Hospital)
view all 5 authors...
Abstract null null Objectives null To demonstrate the use of urine congophilia quantification in the prediction and diagnosis of pre-eclampsia using of Congo red dot test null null null Study design null A prospective cohort study in 378 consecutive pregnant women was conducted. All eligible, consenting women of gestational age between 10 to 34 weeks were enrolled in the study. The presence of urinary misfolded proteins was screened by a simple dot test technique on unsupported nitrocellulose me...
Abstract null null Introduction null Pre-eclampsia (PE) accounts for 14.8% of maternal deaths in South Africa. Tenascin C (TN-C) is an anti-inflammatory cytokine expressed in the extracellular matrix and may be dysregulated in the hyperinflammatory PE microenvironment. null null null Material and methods null This study examined serum TN-C in normotensive pregnant (n = 36) and pre-eclamptic (n = 36) HIV positive and negative women using an immunoassay. null null null Results null TN-C was signif...
#1Marta M. Martínez-Martínez (Foundation for Biomedical Research)
#2Jorge Fernández-Travieso (UEM: European University of Madrid)H-Index: 2
Last. Ambrosio Miralles Martínez (UEM: European University of Madrid)
view all 6 authors...
OBJECTIVES To evaluate maternal cerebral hemodynamics in patients with preeclampsia (PE) from diagnosis to clinical resolution using transcranial Doppler (TCD) and compare these findings with those of healthy pregnant women. Furthermore, we sought to describe the prevalence of vasoconstriction (VC) and related clinical parameters in PE. STUDY DESIGN Case-control study including consecutive patients with PE at diagnosis and healthy pregnant women at week 36 of pregnancy. We prospectively collecte...
#1Joost Henric Nicolaas Schuitemaker (UMCG: University Medical Center Groningen)H-Index: 2
#2Rik H. J. Beernink (UG: University of Groningen)H-Index: 1
Last. Marijke M. Faas (UMCG: University Medical Center Groningen)H-Index: 56
view all 6 authors...
Abstract The large interferon-inducible anti-angiogenic pro-inflammatory GTPase Guanylate Binding Protein-1 (GBP-1) is produced and secreted by activated endothelial cells and is highly induced by inflammatory cytokines and inhibited by angiogenic growth factors. During pregnancy a generalized mild inflammatory response is observed. During preeclampsia this generalized inflammatory response is even further activated and activation of the endothelium occurs. We hypothesized that GBP-1 is increase...
#1Amyna Helou (Monash University)H-Index: 1
#2Kay Stewart (Monash University)H-Index: 31
Last. Johnson George (Monash University)H-Index: 33
view all 3 authors...
Abstract null null Objectives null To assess adherence to anti-hypertensive medication by pregnant women and to identify the factors associated with adherence or lack thereof. null Study Design null Observational study in 100 pregnant women with either chronic hypertension or gestational hypertension who were being treated with at least one anti-hypertensive medication and attending antenatal clinics at one of two maternity hospitals. null In-depth interviews were conducted with a subset of 27 w...
#1Aswathi Jayaram (UIC: University of Illinois at Chicago)
#1Aswathi JayaramH-Index: 7
Last. Catalin S. BuhimschiH-Index: 56
view all 7 authors...
Top fields of study
Gestational hypertension
Bronchopulmonary dysplasia
Hypertension in Pregnancy
Postpartum period
Family medicine
Blood pressure